Filter
1693
Filtered Results: 1693
Text search:
antibiotika
Featured
Recommendations
218
New Publications
441
Language
Document type
No document type
766
Guidelines
321
Studies & Reports
277
Fact sheets
80
Manuals
73
Strategic & Response Plan
66
Training Material
40
Online Courses
15
Brochures
13
Infographics
13
Situation Updates
12
Resource Platforms
10
Videos
6
Dashboards/Maps
1
Countries / Regions
India
118
Kenya
47
South Africa
46
Germany
43
Global
42
Ethiopia
39
Nepal
38
Indonesia
31
Western and Central Europe
27
Nigeria
26
Africa
26
Uganda
22
Tanzania
21
Sierra Leone
20
Bangladesh
20
Ghana
19
Philippines
16
Rwanda
16
Malawi
15
Latin America and the Carribbean
15
Madagascar
14
Namibia
13
Haiti
12
Liberia
10
Congo, Democratic Republic of
10
Zimbabwe
10
Myanmar / Burma
10
Mozambique
9
Burkina Faso
8
Senegal
7
Zambia
7
Syria
7
Eastern Europe
7
Cambodia
6
Eastern Europe and Central Asia
6
Cameroon
5
Benin
5
Eswatini/ Swaziland
5
Lesotho
5
East and Southern Africa
5
South–East Asia Region
5
Tajikistan
5
Mali
4
USA
4
Argentina
4
Ukraine
4
Botswana
4
West and Central Africa
4
Venezuela
4
Vietnam
4
France
4
Spain
4
Guinea
3
Pakistan
3
South Sudan
3
Thailand
3
North Macedonia
3
El Salvador
3
Middle East and North Africa
3
Western Pacific Region
3
Russia
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Somalia
2
Iraq
2
Jordan
2
Afghanistan
2
China
2
Papua New Guinea
2
Sudan
2
Peru
2
Switzerland
2
Serbia
2
Colombia
2
Bolivia
2
Angola
2
Paraguay
2
Asia
2
Fiji
2
Laos
2
Uruguay
2
Morocco
1
Saudi Arabia
1
Niger
1
Lebanon
1
Egypt
1
Gambia
1
Malaysia
1
Central African Republic
1
Brazil
1
Austria
1
Honduras
1
Ecuador
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Other region
1
Solomon Islands
1
Bhutan
1
Armenia
1
Southern Africa
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
606
Clinical Guidelines
238
Women & Child Health
121
Public Health
53
Key Resources
50
Capacity Building
38
Pharmacy & Technologies
19
Toolboxes
AMR
407
TB
95
Rapid Response
81
Caregiver
72
Pharmacy
71
NTDs
63
COVID-19
53
Planetary Health
49
Refugee
46
HIV
44
Global Health Education
31
Cholera
30
Ebola
27
Conflict
22
NCDs
16
Mental Health
12
Disability
9
Specific Hazards
9
Natural Hazards
6
Polio
3
Health Financing Toolbox
2
Zika
1
Cholera which disproportionally impacts poor countries and the most vulnerable continues to affect at least 47 countries across the globe, resulting in an estimated 1.3 – 4 million cases, and 21,000 - 143,000 deaths per year worldwide. In Ethiopia, despite major improvements seen in the increasing...
Cholera is a diarrheal disease caused by the bacterium Vibrio cholera. The infection primarily spreads through contaminated water and food. Symptoms include the onset of acute diarrhea and/or vomiting, muscle cramps, and body weakness. If untreated, the infection can result in rapid dehydration and ...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
Leptospirosis is a zoonotic disease with epidemic potential, especially after a heavy rainfall,
caused by a bacterium called Leptospira. Leptospira interrogans is pathogenic to humans and
animals, with more than 200 serologic variants or serovars. Humans usually acquire
leptospirosis through dire...
Leptospirosis is an infectious disease caused by pathogenic organisms belonging to the genus Leptospira, that are transmitted directly or indirectly from animals to humans. Leptospirosis is a major direct zoonosis. Humanto-human transmission occurs only very rarely.
Mycetoma is a specific chronic, granulomatous, inflammatory disease. It usually involves the subcutaneous tissue, most probably after traumatic inoculation of the causative organism. It has a prolonged, progressive, and indolent course, and, if untreated, it ultimately leads to destruction of the de...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
L’objectif de cette note conceptuelle et du cadre dont elle donne les grandes lignes est l’élimination d’un groupe de MT et de leurs effets pénalisants sur la santé (maladies énumérées au tableau 1 ci-dessous) qui, pris globalement, génèrent une charge tangible pour les personnes touch...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable of testing for priority foodborne hazards. The Pacif...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
The application of digital health technology is growing at a rapid rate in Africa, with the goals of improving the delivery of healthcare services and more effectively reaching out to remote and underserved communities. The lack of enabling guidelines and standards across the continent, on the other...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
This report presents a framework to link science, policy and practice for a comprehensive assessment of climate mitigation and adaptation investments and their impact on human health.The framework proposes to use weather and climate data to forecast health impacts over time, as well as biophysical a...
The 2023 Country Presence Report provides an overview of what WHO does in countries to advance towards the SDGs and implement GPW13, how we do it, with whom we work, and what is needed to overcome challenges for achieving results and impact in countries.
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op...
The content of these guidelines goes beyond the technicalities of medical needs with additional insights into community empowerment, possible access to welfare and economic opportunities and similar issues. If these are adequately explored, the health and quality of life of people affected and their...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
